Hyperbaric oxygen therapy and liver transplantation

HPB

Volumn 9, Issue 3, 2007, Pages 174-182

  Muralidharan, Vijayaragavan ^a   Christophi, Chris ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acute rejection; Hyperbaric oxygen; Ischaemia reperfusion injury; Liver failure; Liver support

Indexed keywords

ALPHA INTERFERON; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; OXYGEN; T LYMPHOCYTE RECEPTOR;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; CRYOPRESERVATION; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HYPERBARIC OXYGEN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LIVER FAILURE; LIVER ISCHEMIA; LIVER NECROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; LYMPHOCYTE FUNCTION; NONHUMAN; OXYGEN SUPPLY; OXYGEN TENSION; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW;

EID: 34250630494     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820601175926     Document Type: Review

References (98)

1. Modan, B., Shpilberg, O., Baruch, Y., Sikuler, E., Anis, E. and Ashur, Y. (1995) The need for liver transplantation: A nationwide estimate based on consensus review. Lancet, 346, pp. 660-662.
2. Malago, M., Hertl, M., Testa, G. and Rogiers, X. (2002) Split liver transplantation: Future use of scarce donor organs?. World J Surg, 26, pp. 275-282.
3. Azoulay, D., Astarcioglu, I., Bismuth, H., Castaing, D., Majno, P. and Adam, R. (1996) Split-liver transplantation: The Paul Brousse policy. Ann Surg, 224, pp. 737-748.
4. Emre, S. (2001) Living donor liver transplantation: A critical review. Transplant Proc, 33, pp. 3456-3457.
5. Fan, ST, Lo, CM, Liu, CL, Yong, BH, Chan, JK and Ng, IO (2000) Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg, 135, pp. 336-340.
6. Azoulay, D., Samuel, D., Castaing, D., Adam, R., Adams, D. and Said, G. (1999) Domino liver transplants for metabolic disorders: Experience with familial amyloidotic polyneuropathy. J Am Coll Surg, 189, pp. 584-593.
7. Mor, E., Klintmalm, GB, Gonwa, TA, Solomon, H., Holman, MJ and Gibbs, JF (1992) The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation, 53, pp. 383-386.
8. Vollmar, B., Glasz, J., Leiderer, R., Post, S. and Menger, MD (1994) Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol, 145, pp. 1421-1431.
9. Vollmar, B., Richter, S. and Menger, MD (1996) Leukocyte stasis in hepatic sinusoids. Am J Physiol, 270, pp. G798-G803.
10. Colletti, LM, Kunkel, SL, Walz, A., Burdick, MD, Kunkel, RG and Wilke, CA (1996) The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology, 23, pp. 506-514.
11. Yoshidome, H., Kato, A., Edwards, MJ and Lentsch, AB (1999) Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology, 30, pp. 203-208.
12. Yoshidome, H., Kato, A., Edwards, MJ and Lentsch, AB (1999) Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol, 277:5, p. L919.
13. Todo, S., Zhu, Y., Zhang, S., Jin, MB, Ishizaki, N. and Tanaka, H. (1997) Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation, 63, pp. 213-217.
14. Zhang, S., Jin, MB, Zhu, Y., Ishizaki, N., Tanaka, H. and Subbotin, VM (1997) Effect of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver. Transplant Proc, 29, pp. 1336-1337.
15. Schnare, M., Barton, GM, Holt, AC, Takeda, K., Akira, S. and Medzhitov, R. (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol, 2, pp. 947-950.
16. Ohashi, K., Burkart, V., Flohe, S. and Kolb, H. (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol, 164, pp. 558-561.
17. Kosieradzki, M., Kuczynska, J., Piwowarska, J., Wegrowicz-Rebandel, I., Kwiatkowski, A. and Lisik, W. (2003) Prognostic significance of free radicals: Mediated injury occurring in the kidney donor. Transplantation, 75, pp. 1221-1227.
18. Wu, HS, Zhang, JX, Wang, L., Tian, Y., Wang, H. and Rotstein, O. (2004) Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int, 3, pp. 250-253.
19. Pasare, C. and Medzhitov, R. (2003) Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science, 299, pp. 1033-1036.
20. Coates, PT, Duncan, FJ, Colvin, BL, Wang, Z., Zahorchak, AF and Shufesky, WJ (2004) In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation, 77, pp. 1080-1089.
21. Katz, E., Mor, E., Schwartz, ME, Theise, N., Patel, T. and Miller, CM (1994) Preservation injury in clinical liver transplantation: Incidence and effect on rejection and survival. Clin Transpl, 8, pp. 492-496.
22. Bjorkbacka, H., Kunjathoor, VV, Moore, KJ, Koehn, S., Ordija, CM and Lee, MA (2004) Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med, 10, pp. 416-421.
23. Kouwenhoven, EA, de Bruin, RW, Bajema, IM, Marquet, RL and Ijzermans, JN (2001) Cold ischemia augments allogeneic-mediated injury in rat kidney allografts. Kidney Int, 59, pp. 1142-1148.
24. Lu, CY, Penfield, JG, Kielar, ML, Vazquez, MA and Jeyarajah, DR (1999) Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process?. Kidney Int, 55, pp. 2157-2168.
25. Zinkernagel, RM and Doherty, PC (1974) Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature, 251, pp. 547-548.
26. Zinkernagel, RM and Doherty, PC (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature, 248, pp. 701-702.
27. Pober, JS, Orosz, CG, Rose, ML and Savage, CO (1996) Can graft endothelial cells initiate a host anti-graft immune response?. Transplantation, 61, pp. 343-349.
28. Weiss, A. and Littman, DR (1994) Signal transduction by lymphocyte antigen receptors. Cell, 76, pp. 263-274.
29. Izquierdo, M., Leevers, SJ, Williams, DH, Marshall, CJ, Weiss, A. and Cantrell, D. (1994) The role of protein kinase C in the regulation of extracellular signal-regulated kinase by the T cell antigen receptor. Eur J Immunol, 24, pp. 2462-2468.
30. Clipstone, NA and Crabtree, GR (1993) Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann N Y Acad Sci, 696, pp. 20-30.
31. Linsley, PS and Ledbetter, JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol, 11, pp. 191-212.
32. Lipman, ML, Stevens, AC and Strom, TB (1994) Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol, 152, pp. 5120-5127.
33. Talmage, DW and Dart, GA (1978) Effect of oxygen pressure during culture on survival of mouse thyroid allografts. Science, 200, pp. 1066-1067.
34. Warren, J., Sacksteder, MR and Thuning, CA (1978) Oxygen immunosuppression: Modification of experimental allergic encephalomyelitis in rodents. J Immunol, 121, pp. 315-320.
35. Jacobs, BB, Thuning, CA, Sacksteder, MR and Warren, J. (1979) Extended skin allograft survival in mice during prolonged exposure to hyperbaric oxygen. Transplantation, 28, pp. 70-72.
36. Saito, K., Tanaka, Y., Ota, T., Eto, S. and Yamashita, U. (1991) Suppressive effect of hyperbaric oxygenation on immune responses of normal and autoimmune mice. Clin Exp Immunol, 86, pp. 322-327.
37. Blink, B van den, van der Kleij, AJ, Versteeg, HH and Peppelenbosch, MP (2002) Immunomodulatory effect of oxygen and pressure. Comp Biochem Physiol A Mol Integr Physiol, 132, pp. 193-197.
38. Weisz, G., Lavy, A., Adir, Y., Melamed, Y., Rubin, D. and Eidelman, S. (1997) Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J Clin Immunol, 17, pp. 154-159.
39. Rocco, M., Antonelli, M., Letizia, V., Alampi, D., Spadetta, G. and Passariello, M. (2001) Lipid peroxidation, circulating cytokine and endothelin 1 levels in healthy volunteers undergoing hyperbaric oxygenation. Minerva Anestesiol, 67, pp. 393-400.
40. Granowitz, EV, Skulsky, EJ, Benson, RM, Wright, J., Garb, JL and Cohen, ER (2002) Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med, 29, pp. 216-225.
41. Huang, KY and Gordon, FB (1968) Production of interferon in mice: Effect of altered gaseous environments. Appl Microbiol, 16, pp. 1551-1556.
42. Hansborough, JF, Piacentine, JG and Eiseman, B. (1980) Immunosuppression by hyperbaric oxygen. Surgery, 87, pp. 662-667.
43. Hohn, DC, MacKay, RD, Halliday, B. and Hunt, TK (1967) Effect of O2 tension on microbicidal function of leukocytes in wounds and in vitro. Surg Forum, 27, pp. 18-20.
44. Gadd, MA, McClellan, DS, Neuman, TS and Hansborough, JF (1990) Effect of hyperbaric oxygen on murine neutrophil and T-lymphocyte functions. Crit Care Med, 18, pp. 974-979.
45. Zoschke, DC and Staite, ND (1987) Suppression of human lymphocyte proliferation by activated neutrophils or H2O2: Surviving cells have an altered T helper/T suppressor ratio and an increased resistance to secondary oxidant exposure. Clin Immunol Immunopathol, 42, pp. 160-170.
46. Staite, ND, Messner, RP and Zoschke, DC (1987) Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes. J Immunol, 139, pp. 2424-2430.
47. Gougerot-Pocidalo, MA, Fay, M. and Pocidalo, JJ (1984) In vivo normobaric oxygen exposure depresses spleen cell in vitro Con A response. Effects of 2-mercaptoethanol and peritoneal cells. Clin Exp Immunol, 58, pp. 428-435.
48. MacKenzie, DA, Sollinger, HA and Hullett, DA (2000) Role of CD4 regulatory T cells in hyperbaric oxygen mediated immune non-responsiveness. Hum Immunol, 61, pp. 1320-1331.
49. Gaulton, GN and Markmann, JF (1988) Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor. Immunol Res, 7, pp. 113-135.
50. Smith, KA (1988) Interleukin-2: Inception, impact, and implications. Science, 240, pp. 1169-1176.
51. Hullett, DA, Landry, AS, Leonard, DK and Sollinger, HW (1989) Enhancement of thyroid allograft survival following organ culture. Tranplantation, 47, pp. 24-27.
52. Hullett, DA, Landry, AS, Leonard, DK and Sollinger, HW (1989) Improved human fetal pancreatic tissue survival following hyperbaric oxygen culture. Transplant Proc, 21, pp. 2659-2660.
53. Hullett, DA, Landry, AS, Leonard, DK and Sollinger, HW (1989) Regulation of class I antigens responsible for prolonged graft survival after organ culture. Transplant Proc, 21, pp. 240-241.
54. MacKenzie, DA, Sollinger, HW and Hullett, DA (2003) Decreased immunogenicity of human fetal pancreas allografts following hyperbaric oxygen culture. Transplant Proc, 35, pp. 1499-1502.
55. Sloan-Lancaster, J. and Allen, PM (1996) Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology. Annu Rev Immunol, 14, pp. 1-27.
56. Sloan-Lancaster, J., Steinberg, TH and Allen, PM (1997) Selective loss of the calcium ion signalling pathway in T cells maturing towards a T helper 2 phenotype. J Immunol, 159, pp. 1160-1168.
57. Nicholson, LB, Greer, JM, Sobel, RA, Lees, MB and Kuchroo, VK (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity, 3, pp. 397-405.
58. Piper, HM, Garcia-Dorado, D. and Ovize, M. (1998) A fresh look at reperfusion injury. Cardiovasc Res, 38, pp. 291-300.
59. Zamboni, WA, Roth, AC, Russell, RC, Graham, B., Suchy, H. and Kucan, JO (1993) Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effects of hyperbaric oxygen. Plast Reconstr Surg, 91, pp. 1110-1123.
60. Kihara, K., Ueno, S., Sakoda, M. and Aikou, T. (2005) Effects of hyperbaric oxygen exposure on experimental hepatic ischemia reperfusion injury: Relationship between its timing and neutrophil sequestration. Liver Transpl, 11, pp. 1574-1580.
61. Thom, S. (1993) Functional inhibition of leucocyte [beta] integrins by hyperbaric oxygen in carbon monoxide mediated brain injury in rats. Toxicol Appl Pharm, 123, pp. 248-256.
62. Larson, JL, Stephenson, LL and Zamboni, WA (2000) Effect of hyperbaric oxygen on neutrophil CD18 expression. Plast Reconstr Surg, 105, pp. 1375-1381.
63. Labrouche, S., Javorschi, S., Leroy, D., Gbikpi-Benissan, G. and Freyburger, G. (1999) Influence of hyperbaric oxygen on leukocyte functions and haemostasis in normal volunteer divers. Thromb Res, 96, pp. 309-315.
64. Buras, JA, Stahl, GL, Svoboda, KK and Reenstra, WR (2000) Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol, 278, pp. C292-C302.
65. Sakoda, M., Ueno, S., Kihara, K., Arikawa, K., Dogomori, H. and Nuruki, K. (2004) A potential role of hyperbaric oxygen exposure through intestinal nuclear factor-kappaB. Crit Care Med, 32, pp. 1722-1729.
66. Ozden, TA, Uzun, H., Bohloli, M., Toklu, AS, Paksoy, M. and Simsek, G. (2004) The effect of hyperbaric oxygen treatment on oxidant and antioxidant levels during liver regeneration in rats. Tohoku J Exp Med, 203, pp. 253-265.
67. Kurir, TT, Markotic, A., Katalinic, V., Bozanic, D., Cikes, V. and Zemunik, T. (2004) Effect of hyperbaric oxygenation on the regeneration of the liver after partial hepatectomy in rats. Braz J Med Biol Res, 37, pp. 1231-1237.
68. Lahat, N., Bitterman, H., Yaniv, N., Kinarty, A. and Bitterman, N. (1995) Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clin Exp Immunol, 102, pp. 655-659.
69. Yang, ZJ, Bosco, G., Montante, A., Ou, XI and Camporesi, EM (2001) Hyperbaric O2 reduces intestinal ischemia-reperfusion-induced TNF-alpha production and lung neutrophil sequestration. Eur J Appl Physiol, 85, pp. 96-103.
70. Benson, RM, Minter, LM, Osborne, BA and Granowitz, EV (2003) Hyperbaric oxygen inhibits stimulus induced proinflammatory cytokine synthesis by human blood derived monocyte macrophages. Clin Exp Immunol, 134, pp. 57-62.
71. Mueller, TH, Kienle, K., Beham, A., Geissler, EK, Jauch, KW and Rentsch, M. (2004) Caspase 3 inhibition improves survival and reduces early graft injury after ischemia and reperfusion in rat liver transplantation. Transplantation, 78, pp. 1267-1273.
72. Yin, D., Zhou, C., Kusaka, I., Calvert, JW, Parent, AD and Nanda, A. (2003) Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab, 23, pp. 855-864.
73. Mizuguchi, T., Oshima, H., Imaizumi, H., Kohara, H., Kawamoto, M. and Nobuoka, T. (2005) Hyperbaric oxygen stimulates cell proliferation and normalizes multidrug resistance protein-2 protein localization in primary rat hepatocytes. Wound Repair Regen, 13, pp. 551-557.
74. Sawai, T., Niimi, A., Takahashi, H. and Ueda, M. (1996) Histologic study of the effect of hyperbaric oxygen therapy on autogenous free bone grafts. J Oral Maxillofac Surg, 54, pp. 975-981.
75. Juang, J-H, Hsu, BR-S, Kuo, C-H and Ueng, SW-N (2002) Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transplant, 11, pp. 95-101.
76. Kutlay, M., Colak, A., Demircan, N., Akin, ON, Kibici, K. and Dundar, K. (2000) Effect of hyperbaric oxygen therapy on fetal spinal grafts: An experimental study. Undersea Hyperb Med, 27, pp. 205-213.
77. Chen, MF, Chen, HM, Ueng, SW and Shyr, MH (1998) Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver, 18, pp. 110-116.
78. Burk, RF, Reiter, R. and Lane, JM (1986) Hyperbaric oxygen protection against carbon tetrachloride hepatotoxicity in the rat. Association with altered metabolism. Gastroenterology, 90, pp. 812-818.
79. Marzella, L., Muhvich, K. and Myers, RA (1986) Effect of hyperoxia on liver necrosis induced by hepatotoxins. Virchows Arch B Cell Pathol Incl Mol Pathol, 51, pp. 497-507.
80. Dubost, T., Goubaux, B., Duhalde, M., Raucoules-Aime, M., Wolkiewiez, J. and Gugenheim, J. (2002) Use of hyperbaric oxygen for hepatic artery thrombosis following adult orthotopic liver transplantation. Eur J Anaesthesiol, 19, pp. 223-224.
81. Mazariegos, GV, O'Toole, K., Mieles, LA, Dvorchik, I., Meza, MP and Briassoulis, G. (1999) Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. Liver Transpl Surg, 5, p. 429.
82. Ponikvar, R., Buturovic, J., Cizman, M., Mekjavic, I., Kandus, A. and Premru, V. (1998) Hyperbaric oxygenation, plasma exchange, and hemodialysis for treatment of acute liver failure in a 3-year-old child. Artif Organs, 22, pp. 952-957.
83. Mizuguchi, K. and Nose, Y. (1994) Hyperbaric oxygenation: Is it an hepatic assist device?. Artif Organs, 18, pp. 545-546.
84. Blum, D., Viart, P., Szliwowski, HB, Thys, JP and Dubois, J. (1972) Exchange transfusion and hyperbaric oxygen in the treatment of children with acute hepatic failure. Helv Paediatr Acta, 27, pp. 425-436.
85. Gill, A. and Bell, CN (2004) Hyperbaric oxygen: Its uses, mechanisms of action and outcomes. Q J Med, 97, pp. 385-395.
86. Pasquier, D., Hoelscher, T., Schmutz, J., Dische, S., Mathieu, D. and Baumann, M. (2004) Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: A literature review. Radiother Oncol, 72, pp. 1-13.
87. Buras, J. (2000) Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anaesthesiol Clin, 38, pp. 91-109.
88. Hansborough, JF and Eiseman, B. (1979) Immunosuppression with hyperbaric oxygen. Surg Forum, 30, pp. 313-315.
89. Hong, JP, Kwon, H., Chung, YK and Jung, SH (2003) The effect of hyperbaric oxygen on ischaemia-reperfusion injury. Ann Plast Surg, 51, pp. 478-487.
90. Kolski, JM, Mazolewski, PJ, Stephenson, LL, Texter, J., Grigoriev, VE and Zamboni, WA (1998) Effect of hyperbaric oxygen therapy on testicular ischemia-reperfusion injury. J Urol, 160, pp. 601-604.
91. Serracio-Inglott, F., Habib, NA and Mathie, RT (2001) Hepatic ischaemia reperfusion. Am J Surg, 181, pp. 160-166.
92. Astarcioglu, H., Karademir, S., Atila, K., Sagol, O., Kocdor, H. and Coker, A. (2004) The effects of vascular bed expansion in steatotic rat liver graft viability. Transpl Int, 17, pp. 188-194.
93. Frankenberg, MV, Weimann, J., Fritz, S., Fiedler, J., Mehrabi, A. and Buchler, MW (2005) Gadolinium chloride-induced improvement of postischemic hepatic perfusion after warm ischemia is associated with reduced hepatic endothelin secretion. Transpl Int, 18, pp. 429-436.
94. Bellamy, MC, Gedney, JA, Buglass, H. and Gooi, JH (2004) Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation. Liver Transpl, 10, pp. 273-278.
95. Arumugam, TV, Woodruff, TM, Stocks, SZ, Proctor, LM, Pollitt, S. and Shiels, IA (2004) Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. J Hepatol, 40, pp. 934-941.
96. Levy, GA (1998) Neoral is superior to FK 506 in liver transplantation. Transplant Proc, 30, pp. 1812-1815.
97. Raimondo, ML, Dagher, L., Papatheodoridis, GV, Rolando, N., Patch, DW and Davidson, BR (2003) Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation, 75, pp. 186-190.
98. Calmus, Y., Scheele, JR, Gonzalez-Pinto, I., Jaurrieta, EJ, Klar, E. and Pageaux, GP (2002) Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl, 8, pp. 123-131.